1. Peto, R., Boreham, J., Clarke, M., Davies, C. & Beral, V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years. Lancet 355, 1822 (2000).
2. Era of Hope Department of Defense Breast Cancer Research Program Meeting, Atlanta, GA, Atlanta Hilton & Towers, June 8–11, 2000.
3. McKenna, N.J., Lanz, R.B. & O'Malley, B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20, 321–344 (1999).
4. Kurebayashi, J. et al. Expression levels of estrogen receptor-α, estrogen receptor-β, coactivators, and co-repressors in breast cancer. Clin. Cancer Res. 6, 512–518 (2000).
5. Graham, J.D., Tung, L., Osborne, C.K., Fuqua, S.A. & Horwitz, K.B. Quantitative analysis of nuclear receptor coregulators in breast cancer (abstr). Keystone Symposia on the Nuclear Receptor Gene Family Lake Tahoe, Nevada (1998).